An analysis of data from 41 health care systems participating in the National Patient-Centered Clinical Research Network found lower use of monoclonal antibody therapies for patients who are Black, Asian or other races compared with white and non-Hispanic patients between November 2020 and August 2021, the Centers for Disease Control and Prevention reported Friday. Among all patients with positive SARS-CoV-2 test results, the overall use of mAb was infrequent, with mean monthly use at 4% or less for all racial and ethnic groups.

In other news, the CDC Friday released updated COVID-19 masking information for consumers to reflect the latest science. The update lays out the protection provided by available masks and respirators, noting that some provide better protection than others.

Related News Articles

Headline
The AHA July 14 responded to a Department of Health and Human Services request for information regarding lawful regulation and innovation to promote better…
Headline
 The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that…
Headline
Duke University’s Anna Tharakan, lead project manager on Closing the Gap on Hypertension Disparities, and Bradi Granger, Ph.D., research professor at Duke…
Headline
A National Institutes of Health study published April 2 found that blood pressure patterns observed during the first half of pregnancy can determine a woman's…
Headline
A study published March 31 by the National Institutes of Health found that adults living in rural areas have worse cardiovascular health than those in urban…
Headline
The AHA’s newly released infographic highlights the importance of leveraging community collaborations to address health disparities for all populations.